Chemical Structure : Quilseconazole
CAS No.: 1340593-70-5
Catalog No.: PC-60051Not For Human Use, Lab Use Only.
A novel selective, orally available fungal CYP51 (lanosterol 14-α-demethylase) inhibitor.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $298 | In stock | |
10 mg | $458 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Quilseconazole (VT-1129) is a selective, orally available fungal CYP51 (lanosterol 14-α-demethylase) inhibitor.
Quilseconazole displays greater selectivity for fungal enzyme than for mammalian CYP450 compared to the approved azole class of antifungal drugs.
Quilseconazole inhibits C. albicans and T. rubrum with MIC of <0.001 ug/mL, also demonstrated potent activities against Cryptococcusspecies as demonstrated by low MIC50 and MIC90 values.
M.Wt | 513.376 | |
Formula | C22H14F7N5O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-{5-[4-(trifluoromethoxy)phenyl]pyridin-2-yl}propan-2-ol |
1. Hoekstra WJ, et al. Bioorg Med Chem Lett. 2014 Aug 1;24(15):3455-8.
2. Lockhart SR, et al. Antimicrob Agents Chemother. 2016 Mar 25;60(4):2528-31.
3. Warrilow AG, et al. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4530-8.
4. Nielsen K, et al. Med Mycol. 2017 Jun 1;55(4):453-456.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright